Clinical Trials

194 enrolled

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Uterine Cervical Neoplasms, Recurrence

NCT04068896 2025-05-29

Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy

Phase 1/2 Completed

89 enrolled 21 charts

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT01220154 2025-02-21

Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer

9 enrolled

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

NCT03246074 2024-10-24

Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer

35 enrolled 16 charts

Ovarian Neoplasms

NCT02020707 2024-07-26

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

DermatologicGenitourinaryGynecologicOther solid neoplasmSarcoma

43 enrolled

Cervical Adenocarcinoma

NCT06391190 2024-04-30

Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer

Phase 1/2 Recruiting

20 enrolled

Locally Advanced Cervical Carcinoma

NCT05983276 2024-02-08

Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer

Phase 2 Recruiting

40 enrolled

Phase EARLY_PHASE1 Withdrawn

Ovarian Neoplasms, Recurrence

NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT03304210 2023-11-07

PIPAC-nabpac

BreastGastrointestinalGynecologic

20 enrolled 16 charts

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms

NCT06055738 2023-09-28

Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC

Phase 2 Recruiting

20 enrolled

Locally Advanced Cervical Cancer

NCT02744898 2023-09-26

A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus

23 enrolled 9 charts

BreastGastrointestinalGynecologic

Endometrial Neoplasms

NCT02762981 2022-12-06

Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid Tumors

Phase 1/2 Completed

85 enrolled 24 charts

Carcinoma, Ovarian Epithelial, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT02117817 2022-07-28

Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer

Phase 1 Withdrawn

Ovarian Neoplasms, Endometrial Neoplasms

NCT05367206 2022-05-10

N6C

Phase 3 Recruiting

280 enrolled

Uterine Cervical Neoplasms

NCT05316376 2022-04-07

Effect of Albumin-bound Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Patients Receiving Neoadjuvant Chemotherapy for Advanced Ovarian, Fallopian Tube or Peritoneal Cancer: A Phase 2 Single Center Clinical Trial

78 enrolled

Ovarian Neoplasms

NCT05310344 2022-04-04

Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer

50 enrolled

Ovarian Neoplasms

NCT05290935 2022-03-22

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial

122 enrolled

Uterine Cervical Neoplasms

NCT04188860 2022-03-15

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy

34 enrolled

Uterine Cervical Neoplasms

NCT04815408 2021-03-25

PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer

40 enrolled

Ovarian Neoplasms

NCT04590625 2020-10-19

Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer

58 enrolled

Ovarian Neoplasms

NCT02476955 2020-09-30

Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole

Phase 1 Terminated

41 enrolled

BreastGynecologic

Uterine Cervical Neoplasms, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT01478685 2019-11-12

A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

GastrointestinalGenitourinaryGynecologicThoracic

169 enrolled

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms, Recurrence, Tumor Virus Infections, Carcinoma, Pancreatic Ductal

NCT00407407 2019-10-18

ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma

Phase 1 Terminated

6 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT03942068 2019-05-08

Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer

35 enrolled

Ovarian Neoplasms

NCT00309959 2019-01-08

ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer

37 enrolled 7 charts

Uterine Cervical Neoplasms

NCT01219777 2018-02-08

Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian

9 enrolled 7 charts

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

NCT00825201 2018-01-19

Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity

27 enrolled

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Peritoneal Neoplasms

NCT00499252 2018-01-11

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

51 enrolled 8 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00585052 2018-01-05

A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer

Phase 2 Terminated

11 enrolled 8 charts

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00466960 2017-08-28

Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy

21 enrolled 12 charts

Carcinoma, Ovarian Epithelial, Brenner Tumor, Fallopian Tube Neoplasms

NCT00313599 2014-07-02

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

BreastCNSGastrointestinalGenitourinaryGynecologicThoracic

28 enrolled

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Dysgerminoma, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Central Nervous System Neoplasms

NCT01821859 2013-07-26

Abraxane/Bevacizumab

Phase 2 Terminated

5 enrolled 3 charts

Ovarian Neoplasms

NCT01667211 2012-08-22

CSAPPPCC

30 enrolled

Uterine Cervical Neoplasms

NCT00407563 2012-04-05

Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer

48 enrolled 11 charts

Carcinoma, Ovarian Epithelial

NCT00466986 2011-10-12

Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer

40 enrolled